Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types
Chandani Limbad1, Ryosuke Doi1, Julia McGirr1
1Buck Institute for Research on Aging, Novato, CA, USA.
Abstract:
Cellular senescence is a driver of many age-related pathologies. There is an active search for pharmaceuticals termed senolytics that can mitigate or remove senescent cells in vivo by targeting genes that promote the survival of senescent cells. We utilized single-cell RNA sequencing to identify CRYAB as a robust senescence-induced gene and potential target for senolysis. Using chemical inhibitor screening for CRYAB disruption, we identified 25-hydroxycholesterol (25HC), an endogenous metabolite of cholesterol biosynthesis, as a potent senolytic. We then validated 25HC as a senolytic in mouse and human cells in culture and in vivo in mouse skeletal muscle. Thus, 25HC represents a potential class of senolytics, which may be useful in combating diseases or physiologies in which cellular senescence is a key driver.
Insights
Researchers identified 25-hydroxycholesterol (25HC) as a novel senolytic drug. This compound effectively clears senescent cells, offering a potential therapeutic strategy for age-related diseases driven by cellular senescence.
Area of Science:
- Gerontology
- Molecular Biology
- Pharmacology
Background:
- Cellular senescence contributes to age-related diseases.
- Senolytics are drugs that eliminate senescent cells.
- Targeting senescence-survival genes is a key senolytic strategy.
Purpose of the Study:
- Identify novel senescence-induced genes for senolytic targeting.
- Discover potent senolytic compounds.
- Validate the senolytic efficacy of identified compounds.
Main Methods:
- Single-cell RNA sequencing to identify senescence-induced genes.
- Chemical inhibitor screening for CRYAB disruption.
- In vitro and in vivo validation of senolytic activity.
Main Results:
- CRYAB was identified as a robust senescence-induced gene.
- 25-hydroxycholesterol (25HC) was identified as a potent senolytic agent.
- 25HC demonstrated senolytic efficacy in human and mouse cells, and in mouse skeletal muscle.
Conclusions:
- 25HC is a potential senolytic compound targeting CRYAB.
- 25HC may be a valuable therapeutic for senescent cell-driven pathologies.
- This discovery opens avenues for new senolytic drug development.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Nuclear Protein Sorting


